health
N-acetylcysteine study reports immune changes in cancer patients with severe COVID-19
A medRxiv preprint reports improved clinical outcomes and changes in immune markers after N-acetylcysteine treatment in cancer patients with severe COVID-19. The clinical comparison used severity-matched patients treated before the trial began.